Skip to main content

ADVERTISEMENT

risk sharing

Research in Review
07/27/2017
JCP Editors
Patients with chronic myeloid leukemia (CML) who attempt to discontinue tyrosine kinase inhibitor (TKI) therapy for a second time after a first unsuccessful attempt have strong treatment-free remission rates,...
Patients with chronic myeloid leukemia (CML) who attempt to discontinue tyrosine kinase inhibitor (TKI) therapy for a second time after a first unsuccessful attempt have strong treatment-free remission rates,...
...
07/27/2017
Journal of Clinical Pathways
Research in Review
07/27/2017
JCP Editors
Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...
Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...
...
07/27/2017
Journal of Clinical Pathways
Research in Review
07/19/2017
JCP Editors
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new...
07/19/2017
Journal of Clinical Pathways
Research in Review
07/10/2017
JCP Editors
A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...
A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...
A...
07/10/2017
Journal of Clinical Pathways
Research in Review
06/29/2017
JCP Editors
Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...
Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...
Adult...
06/29/2017
Journal of Clinical Pathways
Research in Review
06/29/2017
JCP Editors
Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...
Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...
Recent...
06/29/2017
Journal of Clinical Pathways
Research in Review
06/29/2017
JCP Editors
Despite a small decline in chronic opioid use after 2010, recent research suggests that 40% of older patients with rheumatoid arthritis (RA) still take opioids regularly as of 2014, published in Arthritis &...
Despite a small decline in chronic opioid use after 2010, recent research suggests that 40% of older patients with rheumatoid arthritis (RA) still take opioids regularly as of 2014, published in Arthritis &...
...
06/29/2017
Journal of Clinical Pathways
Research in Review
06/28/2017
JCP Editors
Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...
Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...
...
06/28/2017
Journal of Clinical Pathways
Research in Review
06/26/2017
JCP Editors
A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...
A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
06/19/2017
JCP Editors
Research suggests that age can impact the risk of disease progression in low-risk prostate cancer managed with active surveillance, published in the Journal of Clinical Oncology (June 2017;35[17]:1898-1904). Recent...
Research suggests that age can impact the risk of disease progression in low-risk prostate cancer managed with active surveillance, published in the Journal of Clinical Oncology (June 2017;35[17]:1898-1904). Recent...
...
06/19/2017
Journal of Clinical Pathways